373 related articles for article (PubMed ID: 26883112)
1. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.
Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC
Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112
[TBL] [Abstract][Full Text] [Related]
2. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
[TBL] [Abstract][Full Text] [Related]
3. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.
Khammanivong A; Wang C; Sorenson BS; Ross KF; Herzberg MC
PLoS One; 2013; 8(7):e69395. PubMed ID: 23874958
[TBL] [Abstract][Full Text] [Related]
4. Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma.
Argyris PP; Saavedra F; Malz C; Stone IA; Wei Y; Boyle WS; Johnstone KF; Khammanivong A; Herzberg MC
Oral Oncol; 2023 Feb; 137():106304. PubMed ID: 36608459
[TBL] [Abstract][Full Text] [Related]
5. Intracellular calprotectin (S100A8/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma.
Argyris PP; Slama Z; Malz C; Koutlas IG; Pakzad B; Patel K; Kademani D; Khammanivong A; Herzberg MC
Oral Oncol; 2019 Aug; 95():1-10. PubMed ID: 31345374
[TBL] [Abstract][Full Text] [Related]
6. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells.
Silva EJ; Argyris PP; Zou X; Ross KF; Herzberg MC
Int J Biochem Cell Biol; 2014 Oct; 55():279-87. PubMed ID: 25236491
[TBL] [Abstract][Full Text] [Related]
7. S100A8 and S100A9 in inflammation and cancer.
Gebhardt C; Németh J; Angel P; Hess J
Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
[TBL] [Abstract][Full Text] [Related]
8. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
9. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
McNeill E; Hogg N
Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
[TBL] [Abstract][Full Text] [Related]
10. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.
Grebhardt S; Müller-Decker K; Bestvater F; Hershfinkel M; Mayer D
J Cell Physiol; 2014 May; 229(5):661-71. PubMed ID: 24122301
[TBL] [Abstract][Full Text] [Related]
11. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE.
Narumi K; Miyakawa R; Ueda R; Hashimoto H; Yamamoto Y; Yoshida T; Aoki K
J Immunol; 2015 Jun; 194(11):5539-48. PubMed ID: 25911757
[TBL] [Abstract][Full Text] [Related]
14. The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas.
Li Y; Kong F; Jin C; Hu E; Shao Q; Liu J; He D; Xiao X
BMC Cancer; 2019 Jun; 19(1):597. PubMed ID: 31208368
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of S100A8/A9 (calprotectin) in human typhoid fever and the murine Salmonella model.
De Jong HK; Achouiti A; Koh GC; Parry CM; Baker S; Faiz MA; van Dissel JT; Vollaard AM; van Leeuwen EM; Roelofs JJ; de Vos AF; Roth J; van der Poll T; Vogl T; Wiersinga WJ
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003663. PubMed ID: 25860480
[TBL] [Abstract][Full Text] [Related]
16. β-1,3-Galactosyl-
Sumardika IW; Youyi C; Kondo E; Inoue Y; Ruma IMW; Murata H; Kinoshita R; Yamamoto KI; Tomida S; Shien K; Sato H; Yamauchi A; Futami J; Putranto EW; Hibino T; Toyooka S; Nishibori M; Sakaguchi M
Oncol Res; 2018 Apr; 26(3):431-444. PubMed ID: 28923134
[TBL] [Abstract][Full Text] [Related]
17. High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma.
Funk S; Mark R; Bayo P; Flechtenmacher C; Grabe N; Angel P; Plinkert PK; Hess J
Int J Cancer; 2015 May; 136(9):2037-46. PubMed ID: 25302747
[TBL] [Abstract][Full Text] [Related]
18. S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells.
Qin F; Song Y; Li Z; Zhao L; Zhang Y; Geng L
Pathol Oncol Res; 2010 Sep; 16(3):353-60. PubMed ID: 19957061
[TBL] [Abstract][Full Text] [Related]
19. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
[TBL] [Abstract][Full Text] [Related]
20. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
